- Telehealth Visits
- Insurance plan information
Jocelyn Chapman, MD
Gynecologic Oncology • Gynecologic Surgical OncologyCo-director, Multidisciplinary Approach to the Placenta Service- Telehealth Visits
- Insurance plan information
Jocelyn Chapman, MD
Gynecologic Oncology • Gynecologic Surgical OncologyCo-director, Multidisciplinary Approach to the Placenta Service- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jocelyn Chapman specializes in the surgical and medical treatment of gynecologic malignancies. She cares for patients with both cancerous and complex noncancerous diseases of the female reproductive system. In addition to expertise in the aggressive surgical management of advanced ovarian and uterine cancers, she has special training in minimally invasive procedures (laparoscopic and robotic surgery), benefiting appropriately selected patients.
Chapman's clinical research focuses on enhancing surgical and preoperative processes to ensure that all gynecologic cancer patients at UCSF receive safe, superior care. With her expertise in computational genomics, she also collaborates with UCSF cancer researchers to better understand the genetic vulnerabilities in gynecologic cancer and to use them for targeted therapies. Her research has been published in Gynecologic Oncology, Journal of the National Comprehensive Cancer Network and Nature Biotechnology.
Chapman earned her medical degree from Boston University School of Medicine. She completed her residency at UCSF and received specialty training through the joint Stanford-UCSF gynecologic oncology fellowship.
Education & training
Board certification
- Gynecologic Oncology, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Gynecologic Oncology, Stanford University School of Medicine
Residency
- Obstetrics & Gynecology, UCSF School of Medicine -GME
Degree
- MD, Boston University School of Medicine
Academic title
- Clinical Professor
My expertise
Locations
My research
Clinical trials
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal CancerOpens in a new window
Recruiting
To assess percentage of patients with advanced-stage ovarian, fallopian tube, and peritoneal cancers per Response Evaluation Criteria in Solid Tumors (RECIST)1...A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerOpens in a new window
Recruiting
Progression-free survival (PFS) according to RECIST version 1.1, per blinded independent central review (BICR)
Publications
Showing 1-6 of 69 reviews
- April 21, 20265 out of 5 Stars
Dr. Chapman had taken excellent care of me throughout this process. I'm very grateful for her skill, support, and guidance.
- April 4, 20265 out of 5 Stars
I am so fortunate and grateful to be in the care of Dr. Joslyn Chapman and her care team. Everyone is supportive and positive and reassuring as I head into the next step of chemotherapy.
- March 26, 20265 out of 5 Stars
Everyone at UCSF, from the check in, to the nurse assistant to the doctor to the people in the blood lab were all incredibly helpful and kind. I very much appreciate each of them.
- March 24, 20265 out of 5 Stars
My Care Provider was focused on me and my condition with efforts to encourage earlier access of my future appointments. I'm still on a waiting list. It has been 7 days so far.
- March 16, 20265 out of 5 Stars
I love Dr. Chapman and am very thankful she is my Dr. I would recommend her to everyone.
- March 2, 20265 out of 5 Stars
I am so lucky to have UCSF as my health care!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.